financetom
Business
financetom
/
Business
/
Invesco preliminary AUM rises 2% in October to $2.167 trillion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Invesco preliminary AUM rises 2% in October to $2.167 trillion
Nov 11, 2025 1:56 PM

(Corrects timeline for AUM in Key Details to October-end from Q4, clarifies that AUM is preliminary headline and Overview, and that the figure is a month-on-month change)

Overview

* Invesco's ( IVZ ) preliminary AUM rose 2% month-on-month in October to $2.167 trillion, driven by market returns and inflows

* Net long-term inflows for October were $8 bln, with money market inflows at $11.1 bln

* Sale of India business reduced AUM by $15.6 bln, FX decreased AUM by $6.2 bln

Outlook

* Company did not provide specific guidance for future quarters or years

Result Drivers

* MARKET RETURNS - Favorable market returns increased AUM by $38 bln

* NET INFLOWS - Co reported net long-term inflows of $8 bln and money market inflows of $11.1 bln

* INDIA BUSINESS SALE - Sale of India business reduced AUM by $15.6 bln

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

$2.17

trln

OCT-END

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy", 11 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the investment management & fund operators peer group is "buy."

* Wall Street's median 12-month price target for Invesco Ltd ( IVZ ) is $26.00, about 9.1% above its November 10 closing price of $23.64

* The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,557,649, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,557,649, According to a Recent SEC Filing
Sep 2, 2025
04:21 PM EDT, 09/02/2025 (MT Newswires) -- Tolga Tanguler, Executive Vice President, Chief Commercial Officer, on August 29, 2025, sold 3,474 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,557,649. Following the Form 4 filing with the SEC, Tanguler has control over a total of 25,992 common shares of the company, with 25,992 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1178670/000173527625000094/xslF345X05/edgardoc.xml ...
GitLab Appoints Manav Khurana as Chief Product, Marketing Officer; Manu Narayan as Chief Information Officer
GitLab Appoints Manav Khurana as Chief Product, Marketing Officer; Manu Narayan as Chief Information Officer
Sep 2, 2025
04:24 PM EDT, 09/02/2025 (MT Newswires) -- GitLab ( GTLB ) said late Tuesday it has appointed Manav Khurana as chief product and marketing officer and Manu Narayan as chief information officer. Khurana previously worked as the chief product officer at New Relic, while Narayan served as the vice president of business technology at Confluent, the company said. ...
Bruker Launches $600 Million Mandatory Convertible Preferred Stock Offering
Bruker Launches $600 Million Mandatory Convertible Preferred Stock Offering
Sep 2, 2025
04:26 PM EDT, 09/02/2025 (MT Newswires) -- Bruker ( BRKR ) said late Tuesday it launched a public offering of $600 million in mandatory convertible preferred stock, series A. Underwriters were granted a 30-day option to buy up to an additional $90 million to cover over-allotments. The offering includes 2.4 million shares, rising to 2.76 million if the option is...
Zscaler Fiscal Q4 Adjusted Earnings, Revenue Rise; Issues Outlook
Zscaler Fiscal Q4 Adjusted Earnings, Revenue Rise; Issues Outlook
Sep 2, 2025
04:22 PM EDT, 09/02/2025 (MT Newswires) -- Zscaler ( ZS ) reported fiscal Q4 adjusted earnings late Tuesday of $0.89 per diluted share, up from $0.72 a year earlier. Analysts polled by FactSet expected $0.80. Revenue for the quarter ended July 31 was $719.2 million, up from $592.9 million a year earlier. Analysts surveyed by FactSet expected $706.9 million. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved